Here are the key administration guidelines: Choose injection sites with adequate fatty tissue: Abdomen (avoiding the belly button) Love handles Upper arm area Inner thigh region Always rotate injection sites to prevent tissue damage and maintain absorption efficiency
Switching to a lower maintenance dose, rather than stopping completely, is a common approach
People who are pregnant, breastfeeding, dealing with serious medical conditions, taking prescription medications, undergoing cancer treatment, or managing immune-related conditions should be especially cautious
[37] Minimal reported side effects across animal and limited human pilot data
Research Compound Summary Compound: TB-500 (Thymosin Beta-4 Fragment) CAS Number: 77591-33-4 Molecular Formula: C212H350N56O78S Purity: 98.62% (HPLC-UV verified) Third-Party Testing: Testides Analytical (independent lab, Toronto) COA Download: View Full COA (PDF) Report: DBAV-TB500-10-051226 Source: Canadian manufactured Shipping: Same-day from our BC facility TB-500 peptide Canada: a synthetic version of a 43-amino acid region of Thymosin Beta-4 (TB4), a naturally occurring protein involved in cell migration and differentiation research